Search - tctmd.com

Displaying 101 - 120 of 273

Sort: Relevancy | Date

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Shelley Wood

March 28, 2016

News Industry News

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

March 16, 2016

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

March 01, 2016

News Conference News CRT 2016

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

Shelley Wood

February 21, 2016

News Daily News

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Michael O'Riordan

February 08, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

Michael O'Riordan

February 08, 2016

News Daily News

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

L.A. McKeown

February 07, 2016

News Daily News

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

L.A. McKeown

February 07, 2016

News Daily News

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Michael O'Riordan

December 27, 2015

News Daily News

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

Michael O'Riordan

December 27, 2015

News Daily News

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Michael O'Riordan

December 27, 2015

News Daily News

报告首次概述了商业化 TAVR 的经验

Todd Neale

November 30, 2015

News Daily News

Un Informe Ofrece una Visión de la Experiencia Comercial Inicial de la TAVR

Todd Neale

November 30, 2015

News Daily News

Report Provides Snapshot of Initial Commercial TAVR Experience

Todd Neale

November 30, 2015

Advertisement

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

报告首次概述了商业化 TAVR 的经验

Un Informe Ofrece una Visión de la Experiencia Comercial Inicial de la TAVR

Report Provides Snapshot of Initial Commercial TAVR Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content